Specifications TableSubject*Biology*Specific subject area*Genetics*Type of data*Table and figure*How data were acquired*MALDI/TOF mass spectrometry using Sequenom MassARRAY 4.0 platform (Agena Bioscience™)*Data format*Raw and analyzed data*Parameters for data collection*Total genomic DNA was isolated from buffy coat using the standard phenol-chloroform method.*Description of data collection*DNA samples were genotyped using the Sequenom MassARRAY® iPLEX platform, which is based on MALDI-TOF (matrix-assisted laser desorption/ionization time-of-flight) mass spectrometry*Data source location*Belgorod, Russia*Data accessibility*The data is available with this article***Value of the Data**•The frequencies of alleles, genotypes and haplotypes of rs3126085, rs12144049, rs471144 and rs4363385 of the FLG gene in Russian were not differed between males and females with AD.•The polymorphisms at the FLG gene may associate with atopic dermatitis.•The allele, genotype and haplotype frequencies are an important data for understanding the genetic architecture of different populations.•The data can be used for studying the genetic basis of atopic dermatitis and other skin (i.e. psoriasis) or allergic disease (i.e. asthma) in various populations of the world.

1. Data description {#sec1}
===================

The dataset represents the raw data ([supplementary Table](#appsec1){ref-type="sec"}), frequencies of alleles, genotypes ([Table 1](#tbl1){ref-type="table"}) and haplotypes ([Fig. 1](#fig1){ref-type="fig"}, [Table 2](#tbl2){ref-type="table"}) for four single nucleotide polymorphisms (SNPs) (rs3126085, rs12144049, rs471144 and rs4363385) *filaggrin* (*FLG*) gene in Russian patients with atopic dermatitis (AD). These SNPs were associated with AD in previously published genome-wide association studies (GWAS) ([Table 3](#tbl3){ref-type="table"}) and also candidate gene studies <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738205/> \[[@bib1], [@bib2], [@bib3], [@bib4], [@bib5]\], have significant regulatory potential ([Table 4](#tbl4){ref-type="table"}) and influence gene expression level ([Table 5](#tbl5){ref-type="table"}). The dataset frequencies of the SNP alleles, genotypes and haplotypes were divided into three groups: entire sample, females and males. The minor allele frequency (MAF) for rs3126085 -- 0.1443 (female -- 0.1477, male -- 0.1372), rs12144049 -- 0.2300 (female -- 0.2363, male -- 0.2168), rs471144 -- 0.0714 (female -- 0.0823, male -- 0.0487) and rs4363385 -- 0.4243 (female -- 0.4283, male -- 0.4159). No significant differences in the allele, genotype and haplotype frequencies were found between males and females with AD patients.Table 1The frequencies of alleles and genotypes for single nucleotide polymorphisms (SNPs) rs3126085, rs12144049, rs471144 and rs4363385 in *FLG* gene in Russian patients with atopic dermatitis.Table 1SNP genotype or alleleAll (n = 350)Female (n = 237)Male (n = 113)nfrequencynfrequencynfrequencyrs3126085AA120.034290.038030.0265GA770.2200520.2194250.2212GG2610.74571760.7426850.7522A1010.1443700.1477310.1372G5990.85574040.85231950.8628rs12144049GG260.0743180.075980.0708AG1090.3114760.3207330.2920AA2150.61431430.6034720.6372G1610.23001120.2363490.2168A5390.77003620.76371770.7832rs471144TT40.011440.016900.0000GT420.1200310.1308110.0973GG3040.86862020.85231020.9027T500.0714390.0823110.0487G6500.92864350.91772150.9513rs4363385AA660.1886450.1899210.1858GA1650.47141130.4768520.4602GG1190.3400790.3333400.3540A2970.42432030.4283940.4159G4030.57572710.57171320.5841Fig. 1Linkage disequilibrium (LD) between SNPs rs3126085, rs12144049, rs471144, and rs4363385 of the *FLG* gene in Russian patients with atopic dermatitis. LD measures are presented as Lewontin\'s standardized coefficient D′ (Figure, A) and the square of the correlation Pearson\'s coefficient (r^2^) between SNPs (Figure, B). D′ values vary gradually from white color (D′ = 0, no LD between SNPs) to dark red (D′ = 1, SNPs are in complete LD). Figure sections 1, 2 and 3 represent entire sample, females, and males, respectively.Fig. 1Table 2The frequencies of haplotypes for haploblock of single nucleotide polymorphisms (SNPs) rs3126085 and rs12144049 in *FLG* gene in Russian patients with atopic dermatitis.Table 2Haplotype (rs3126085 and rs12144049)All (n = 350), frequencyFemale (n = 237), frequencyMale (n = 113), frequencyGA0.6380.6260.656GG0.2240.2320.212AA0.1380.1420.132Table 3The literature data about associations of the studied polymorphisms with atopic dermatitis (GWAS data).Table 3SNPPosition (hg38)Association (significance)Referencers3126085152,328,341OR = 1.22 (p = 6 × 10^−12^)\[[@bib1]\]rs12144049152,468,434OR = 1.53 (p = 3 × 10^−30^)\[[@bib2]\]OR = 1.39 (p = 1 × 10^−16^)\[[@bib3]\]rs471144152,481,779OR = 1.54 (p = 2 × 10^−12^)\[[@bib2]\]rs4363385153,016,845OR = 1.23 (p = 2 × 10^−17^)\[[@bib2]\]Table 4Regulatory effects of the 4 SNPs of the FLG gene (HaploReg, v4.1, update 05.11.2015) (<https://pubs.broadinstitute.org/mammals/haploreg/haploreg.php>).Table 4chrpos (hg38)variantRefAltAFRAMRASNEURSiPhyPromoterEnhancerDNAseProteinsMotifsNHGRI/EBIGRASP QTLSelected eQTLGENCODEdbSNPfreqfreqfreqfreqconshistone markshistone marksboundchangedGWAS hitshitshitsgenesfunc annot1152328341rs3126085GA0.530.360.590.157 tissuesFoxp3,TEF1 hit1 hit26 hitsFLG-AS1intronic1152468434rs12144049CT0.670.80.760.74Irf,Obox6,ZEB12 hits1 hit23kb 3′ of RP1-91G5.31152481779rs471144TG0.060.080.180.08LIV, GI7 altered motifs1 hit29kb 5′ of LCE5A1153016845rs4363385TC0.780.540.660.593 hits7 hits4.2kb 5′ of SNORA31Table 5The cis-eQTL values of the 4 SNPs of the FLG gene in skin (according to Genotype-Tissue Expression (GTEx) (<http://www.gtexportal.org/>)).Table 5SNPGene expressionReference alleleAlternative alleleEffect Size (β)*P*-ValueTissuers3126085*FLG*GA−0.220.000000037Skin - Sun Exposed (Lower leg)*RP1-91G5.3*GA0.380.00002Skin - Sun Exposed (Lower leg)rs12144049*CRNN*CT−0.30.00000000096Skin - Sun Exposed (Lower leg)*CRNN*CT−0.320.00000003Skin - Not Sun Exposed (Suprapubic)rs471144*FLG-AS1*TG−0.510.000023Skin - Not Sun Exposed (Suprapubic)rs4363385*SPRR1B*TC−0.250.00000000011Skin - Sun Exposed (Lower leg)*SPRR2D*TC0.270.0000000045Skin - Sun Exposed (Lower leg)*LCE3C*TC−0.340.000000033Skin - Sun Exposed (Lower leg)*LCE3C*TC−0.340.000000033Skin - Not Sun Exposed (Suprapubic)*SPRR2B*TC−0.240.00000081Skin - Sun Exposed (Lower leg)*LCE1D*TC−0.270.0000014Skin - Not Sun Exposed (Suprapubic)*SPRR1B*TC−0.180.0000025Skin - Not Sun Exposed (Suprapubic)*LCE1D*TC−0.240.0000046Skin - Sun Exposed (Lower leg)*SPRR2B*TC−0.240.000014Skin - Not Sun Exposed (Suprapubic)

2. Experimental design, materials, and methods {#sec2}
==============================================

2.1. Subjects selection {#sec2.1}
-----------------------

During a period between 2010 and 2016, AD patients were recruited at Dermatovenerologic dispensaries of Belgorod and Kursk regions (Russia). AD was diagnosed by experienced dermatologists according to the UK Diagnostic Criteria \[[@bib6]\]. The participants were unrelated Russians born in the Central Russia \[[@bib7]\]. The exclusion criteria were as follows: malignant tumors, severe autoimmune diseases, chronic severe diseases of the vital organs (heart, respiratory or renal failure). A total of 350 patients with AD (237 female and 113 male) met these criteria. This work was approved by the Regional Ethics Committee of Belgorod State University and informed consents were obtained from all participants.

2.2. DNA analysis {#sec2.2}
-----------------

The procedures of whole blood sampling, genomic DNA isolation were described elsewhere \[[@bib8]\].

Four SNPs in the *FLG* gene such as rs3126085, rs12144049, rs471144 and rs4363385 were selected for the analysis according to the following criteria \[[@bib9]\]: 1) a SNP was reported to be associated with AD risk by genome-wide association, 2) SNP possesses a regulatory potential (regSNP), 3) SNP is associated with changes in gene expression (eSNP), and 4) MAF ≥ 5%.

The selected SNPs were found to be associated with the risk of AD, as previously reported by genome-wide association studies ([Table 3](#tbl3){ref-type="table"}) and were found to be functionally significant polymorphisms, i.e. they possess significant regulatory potential ([Table 4](#tbl4){ref-type="table"}), as determined by the HaploReg online tools, v4.1 update 05.11.2015 (<https://pubs.broadinstitute.org/mammals/haploreg/haploreg.php>), and have impact on gene expression level ([Table 5](#tbl5){ref-type="table"}), as determined by the GTExportal, (<http://www.gtexportal.org>).

DNA samples were genotyped using the MALDI-TOF mass spectrometry iPLEX platform (Agena Bioscience Inc, San Diego, CA). To ensure quality control of genotyping blind replicates were included. Laboratory personnel involved in genotyping were completely blinded to patients' information. The repeatability test for 5% of randomly selected samples was performed, yielded 100% reproducibility.

2.3. Statistical analysis {#sec2.3}
-------------------------

Genotypes for the polymorphisms were evaluated regarding their accordance to Hardy-Weinberg equilibrium (HWE) using the chi-square test. Differences in allele, genotype and haplotype frequencies between females and males with AD were assessed by the Kruskall-Wallis test. The linkage disequilibrium (LD) between rs3126085, rs12144049, rs471144 and rs4363385 FLG gene was analyzed using Haploview version 4.2 software (<https://www.broadinstitute.org/haploview/haploview>). The LD block structure was determined using the Solid Spine of the LD algorithm \[[@bib10]\] provided by the Haploview 4.2. The degree of genetic linkage between the 4 SNPs in 3 groups was estimated as Lewontin\'s coefficient D′ and squared Pearson\'s correlation coefficient r^2^. D′ values vary gradually from white color (D′ = 0, no LD between SNPs) to dark red (D′ = 1, SNPs are in complete LD). ([Fig. 1](#fig1){ref-type="fig"}).
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